MINNESOTA BOARD OF PHARMACY BIENNIAL REPORT JULY 1, 2000 TO JUNE 30, 2002

Similar documents
Minnesota Board ofexaminers for Nursing Home Administrators Biennial Report July 1,2000 to June 30,2002. Ie General Information

Minnesota Board of Nursing. Biennial Report FY

Minnesota Board of Nursing. Biennial Report FY

APPROVED REGULATION OF THE STATE BOARD OF PHARMACY. LCB File No. R Effective May 16, 2018

Joseph J. Bova, RPh. This program has been brought to you by PharmCon

BIENNIAL REPORT OF THE MINNESOTA BOARD OF OPTOMETRY. STATUTORY AUTHORITY: Minnesota Statutes Sections to ; to 214.

Academic Year

Health Professionals Services Program Biennial Report Fiscal Year July 1, 2000 to June 30, 2002

MEMO. DATE June Licensed Speech-Language Pathologist and Audiologist, Applicants for licenses and other interested persons

(b) Service consultation. The facility must employ or obtain the services of a licensed pharmacist who-

Pharmaceutical Services Requirements: formerly 10D and 10C.7

RULES OF THE TENNESSEE BOARD OF PHARMACY CHAPTER INTRODUCTORY RULES TABLE OF CONTENTS

Frequently Asked Questions

RULES AND REGULATIONS OF THE MAINE STATE BOARD OF NURSING CHAPTER 4

Prescription Monitoring Program State Profiles - California

Applicable State Licensing Requirements for Combined Federal and Comprehensive HHA Survey

Report of the Task Force on Manpower Shortage

ALABAMA STATE BOARD OF PHARMACY ADMINISTRATIVE CODE CHAPTER 680-X-2 PRACTICE OF PHARMACY TABLE OF CONTENTS

OREGON HEALTH AUTHORITY, DIVISION OF MEDICAL ASSISTANCE PROGRAMS

Title 32: PROFESSIONS AND OCCUPATIONS

F.S PHARMACY Ch. 465 CHAPTER 465 PHARMACY

CHAPTER 29 PHARMACY TECHNICIANS

SECTION HOSPITALS: OTHER HEALTH FACILITIES

Definitions: In this chapter, unless the context or subject matter otherwise requires:

FLORIDA ~ STATUTE , and Florida Statutes

At a Glance. Compliance Division. by the board.

a remote pharmacy is not necessarily intended to provide permanent??? how do we make it so that it may be only for limited duration.

State of Arizona Board of Behavioral Health Examiners

BOARD OF VETERINARY MEDICINE FREQUENTLY ASKED QUESTIONS AND ANSWERS

IC Chapter 19. Regulation of Pharmacy Technicians

CHAPTER 37 - BOARD OF NURSING HOME ADMINISTRATORS SUBCHAPTER 37B - DEPARTMENTAL RULES SECTION GENERAL PROVISIONS

CHAPTER TWO LICENSURE: RN, LPN, AND LPTN

Subject to Filing with Minister of Health

78th OREGON LEGISLATIVE ASSEMBLY Regular Session. House Bill 2028 SUMMARY

NC General Statutes - Chapter 90 Article 18D 1

Pharmacy Law Update for Pharmacists & Technicians October 1, 2017 Greg Baran, B.S., Pharm., M.A.

The South African Pharmacy Council An introduction to our Legal Team

Secretary of State Office of Professional Regulation BOARD OF PHARMACY 89 Main Street, 3 rd Floor Montpelier, VT

CARE FACILITIES PART 300 SKILLED NURSING AND INTERMEDIATE CARE FACILITIES CODE SECTION MEDICATION POLICIES AND PROCEDURES

California Pharmacy Law Update 2018

GENERAL ASSEMBLY OF NORTH CAROLINA SESSION 2011 H 1 HOUSE BILL 639. Short Title: Clinical Exercise Physiologist Licensure.

Registration and Licensure as a Pharmacy Technician

DC Board of Pharmacy and Pharmaceutical Control Update

Bold blue=new language Red strikethrough=deleted language Regular text=existing language Bold Green = new changes following public hearing

Jurisprudence Examination Information

1. What is your department s primary purpose and objectives?

PROPOSED REGULATION OF THE CHIROPRACTIC PHYSICIANS BOARD OF NEVADA. LCB File No. R July 19, 2017

APPLICATION NATUROPATHIC PHYSICIAN INSTRUCTION TO APPLICANTS

STATE OF FLORIDA DEPARTMENT OF HEALTH

STATE OF MICHIGAN DEPARTMENT OF LICENSING AND REGULATORY AFFAIRS BUREAU OF PROFESSIONAL LICENSING BOARD OF PHARMACY DISCIPLINARY SUBCOMMITTEE

TITLE 15 LEGISLATIVE RULE WEST VIRGINIA BOARD OF PHARMACY SERIES 1 LICENSURE AND PRACTICE OF PHARMACY

NATUROPATHIC PHYSICIAN APPLICATION FOR NATUROPATH PHYSICAN LICENSURE INSTRUCTION TO APPLICANTS

H 5497 S T A T E O F R H O D E I S L A N D

TN Specific Ethics 2 Hours CPE. David Haddock, EDd,CPA

CONSULTANT PHARMACIST INSPECTION LAW REVIEW

HP0860, LD 1241, item 1, 124th Maine State Legislature An Act To Require Licensing for Certain Mechanical Trades

Committee on Pharmacy Practice

Prescription Monitoring Program State Profiles - Michigan

The Board of Registration of Social Workers

Reporting Requirements and Exemptions to Reporting

INFORMAL SETTLEMENT CONFERENCES GEORGE M. DING JOHN J. BARBERA

STATE OF FLORIDA DEPARTMENT OF HEALTH

INSTRUCTION TO APPLICANTS A. ADMINISTRATOR IN TRAINING PROGRAM:

States that Allow Prescribers and/or Dispensers to Appoint a Delegate to Access the PMP

PHARMACITS COUNCIL OF NIGERIA ACT (1992 No. 91) REGISTRATION OF PHARMACEUTICAL PREMISES REGULATIONS, 2005.

CODE OF ALABAMA 1975

PHARMACY RULES COMMITTEE of the PHARMACY EXAMINING BOARD

Title 32: PROFESSIONS AND OCCUPATIONS

IC Chapter 13. Regulation of Pharmacists and Pharmacies ) Creation of Board

Session of 2008 No AN ACT

Department of Health Presentation: May 18 th Presenters: Jacqueline Jones and Bonnie Stevens

TITLE 4. PROFESSIONS AND OCCUPATIONS CHAPTER 33. BOARD OF EXAMINERS FOR NURSING CARE INSTITUTION ADMINISTRATORS AND ASSISTED LIVING FACILITY MANAGERS

POSITION STATEMENT. - desires to protect the public from students who are chemically impaired.

PATIENT RIGHTS TO ACCESS PERSONAL MEDICAL RECORDS California Health & Safety Code Section

Counselor, Social Worker & Marriage and Family Therapist Board

Understanding the Pharmacy and Drug Act amendments and mail order pharmacy licensing

Recommendations from Florida Assisted Living Association

2015 Annual Convention

Healthcare Professions Registration and Standards Act 2007

The Pharmacy and Pharmacy Disciplines Act SASKATCHEWAN COLLEGE OF PHARMACY PROFESSIONALS REGULATORY BYLAWS

States that Allow Prescribers and/or Dispensers to Appoint a Delegate to Access the PMP

LEGISLATIVE RESEARCH COMMISSION PDF VERSION

CHAPTER Committee Substitute for House Bill No. 29

NC General Statutes - Chapter 90 Article 4A 1

MARYLAND BOARD OF PHYSICIANS P.O. Box 2571 Baltimore, Maryland

Effective Date: 11/09 Policy Chronicle:

N EWSLETTER. Volume Nine - Number Ten October Unprofessional Conduct: MD Accountability for the Actions of a Physician Assistant

The Washington State Pharmacy Practice Act. Objectives. Pharmacy Act RCW cont.. Pharmacy Act RCW

10/4/12. Controlled Substances Dispensing Issues and Solutions. Objectives. Financial Disclosure

CHAPTER ONE GENERAL PROVISIONS

SENATE APPROPRIATIONS COMMITTEE FISCAL NOTE

TECHNICIAN LAW REVIEW. Objectives. Outline 9/20/2012

Massachusetts Integrated Application for Re-Credentialing/Re-Appointment

Safety in the Pharmacy

2018 House of Delegates Report of the Policy Review Committee

BON RULE CHANGES. Rule 213. Practice & Procedure Corrective Action Deferred Action K-STAR (New Rule)

South Carolina Board of Pharmacy

HOUSE BILL NO. HB0296. Representative(s) Zwonitzer, Dv. and Meyer and Senator(s) Johnson A BILL. for

(No. 247) (Approved September 3, 2004) AN ACT

CHAPTER 18. STATE BOARD OF MEDICINE PRACTITIONERS OTHER THAN MEDICAL DOCTORS

Transcription:

This document is made available electronically by the Minnesota Legislative Reference Library as part of an ongoing digital archiving project. http://www.leg.state.mn.us/lrl/lrl.asp MINNESOTA BOARD OF PHARMACY BIENNIAL REPORT JULY 1, 2000 TO JUNE 30, 2002 I. GENERAL INFORMATION A. Board Mission and Major Functions Board ofpharmacy Mission The mission ofthe Minnesota Board of Pharmacy is to promote, preselve, and protect the public health, safety, and welfare by fostering the provision ofquality pharmaceutical care to the citizens ofminnesot~ through the regulation of: the practice of pharmacy; the operation of pharmacies; and the distribution of prescription drugs in the public interest. Board ofpharmacy Functions Setting educational and examination standards for initial and continuing licensure; andadministering clinicalportions oftheexaminations. Reviewing pharmacy related functions and required knowledge, skills and abilities to aid in determining what requirements to set for initial and continuing licensure. Settinglicensure and internship requirements throughthe rules process. Reviewing academic programs to determine ifthey meet requirements. Developing and administering the state's practical examination to. determine candidate ability to apply didactic knowledge to the clinical setting. Developing the state's jurisprudence examination to determine candidate knowledge ofminnesota statutes and rules governing pharmacy practice. Reviewing continuing education programs submitted by sponsors and individuals to determine ifthey meet requirements. Reviewing individual applicant/licensee documentation of completion of requirements for initial and continuing licensure.

Conducting unannouncedinspections ofallpharmacies, drug wholesale houses and dmg manufacturers in the state. Inspect all pharmacies located in the state of Minnesota to assure compliance with all statues and rules relating to prescription drug distribution and the provision ofpharmaceutical care. Inspect all wholesalers located in the state of Minnesota to assure compliance with all statues and rules relating to the storage and distribution ofprescription and non.prescription drugs. Inspect all manufacturers located in the state of Minnesota to assure compliance with Good Manufacturing Practices Standards. Promptly responding to public and agency inquiries, complaints, and reports regarding licensure and conduct ofapplicants, registrants, and licensees. Accepting complaints and reports from the public and health care providers and regulators. Deciding whether a complaint or inquiry is jurisdictional and, if so, whether and what type ofaction to pursue to resolve the matter. Referring inquiries and complaints to other investigative" regulatory, or assisting agencies. Responding to complainants and agency reports by informing the complainants/agencies of action taken to resolve their complaints, while observing provisions of the data practices act regarding the legal status of data obtained during the course of an investigation and disciplinary proceeding. Setting standards of practice and conduct for licensees and pursuing educational or disciplinary action with licensees, to ensure that standards are met Setting standards ofconduct and a basis for disciplinary action throughthe rules process. Seeking information directly from the licensee and securing investigation and fact-finding information from other agencies in response to complaints or inquiries. Helding conferences with licensees to identity their role and responsibility in a matter under investigation. Providing applicant and licensees education to improve practice and prevent recurrence ofproblems. Obtaining voluntary agreement to disciplinary action or pursuing disciplinary action through a due process, contested case hearing, and potential court action. Referring cases, where appropriate, to the Health Professional Services Program.

.,. Providing information and education about licensure requirements, standards ofpractice, and Minnesota drug law to the public and to other interested audiences. Providing information to the pharmacy community concerning requirements for licensure. Providing information to licensees to prevent inappropriate practice and to improve the practice ofpharmacy. Providing the public with information about pharmacy services and drug use issues through telephone, written, and e-mail communications. Providing the public and licensees access to a wide variety of pharmacy related information sources through our web site. B. Major activities during the biennium. The board accomplished the following major activities during the biennium: Continuous updating of a web site to provide information about the board and its various functions for access by the public, applicants for licensure, and licensees of the board. The site provides links to other sites, in state and federal government, to help persons interested in finding appropriate pharmacy services and to inform them of how to pursue complaints or concerns about their prescriptions. It also provides a variety offorms that the public, applicants for licensure, and licensees ofthe board can download. Work on revision of board rules relating to standards of practice for pharmacists. Updated an item pool of2,000+ questions for the Multistate Pharmacy Jurisprudence Examination/Minnesota. Completed development ofa disciplinary database system.

c. Emerging {ssues regarding the regulation ofthe practice ofpharmacy. Emerging issues regarding the regulation ofthe practice ofpharmacy Pharmacy manpower - The profession ofpharmacy is currently faced with a significant shortage oflicensed practitioners. A recent study by the University ofminnesota College ofpharmacy estimates that there are currently 200 to 400 unfillable vacancies for pharmacists in Minnesota. As the baby boomers begin to approach age 55+ and begin to use more prescription drugs the demand for pharmacists will increase. It is estimated that the current nationwide prescription volume will double in the next five years while the number ofpharmacists will increase by only 15 %. To address this issue, the College ofpharmacy at the University of Minnesota obtained funding to open a satellite college ofpharmacy at UMD. This will increase the number ofgraduating students from the current figure of 100 to a figure of150. The Board has already taken steps to streamline the licensing process for both new graduates and pharmacists from other states. The Board ofpharmacy supports the effort by the college ofpharmacy in increasing the supply ofgraduates entering the profession. Rural Pharmacy Initiatives - S~dies by the University ofminnesota College ofpharmacy, using Board ofpharmacy data, have shown that pharmacy services to rural Minnesota may soon be facing a crisis. Two factors are responsible for this looming problem. First, the study has shown that in many rural counties in Minnesota the average age ofthe pharmacists practicing in those counties is 60+. As these pharmacists begin to retire it will be crucial to find younger pharmacists to replace them. The current pharmacist shortage makes this very difficult. Second, pressure from 3 rd party insurance plans to continually reduce the margins on prescription dispensing make owning a pharmacy less and less profitable and make it less likely that independent pharmacy owners in rural counties will be able to attract a buyer for their pharmacies when they retire. As a result, many rural communities may find themselves without pharmacy services in the next few years. The Board is working with and is supportive ofthe Minnesota Pharmacists Association in its legislative initiatives to address this issue.

II. BOARD'S MEMBER, STAFF, AND BUDGET A. Board Composition: Statute requires the Board to have seven members. The names ofthe people appointed, by the Governor, for staggered four-year terms, as of June 30, 2002, are: NAME RESIDENCE PHARMACISTIPUBLIC MEMBER Thomas Dickson Proctor, MN Pharmacist Member Gary Schneider Plymouth, MN Pharmacist Member Jean Lemberg Arden Hills, MN Public Member CarolPeterson Owatonna, MN Public Member Vernon Kassekert White Bear Lake, MN Pharmacist Member Charles Cooper Eagan,MN Pharmacist Member Betty Johnson Elbow Lake, MN Pharmacist Member B. Employees The Board has ten full-time and one part-time positions. They are a full-time executive director, full-time office manager, five full-time pharmacy surveyors, and three and a halfclericals.. C. Receipts, disbursements, and majorfees assessed by theboard. ITEM FY 2001 FY2002 Receipts $1,200,000 $1,254,000 Disbursements $1,016,000 $1,033,000 FEE NAME FEE AMOUNT Pharmacist Renewal $105.00 PracticalExaroination Application $125.00 Original Licensure $105.00 Reciprocity Application $205.00 Pharmacy New and Renewal $165.00. Wholesaler New & Renew-Prescription $180.00 and Controlled Substance Wholesaler - Non-Prescription and $155.00 Veterinary Non-Prescription Wholesaler - Medical Gases $130.00 Wholesaler - When licensed as a :MN $105.00 Pharmacy Manufacturer - Prescription and $180.00

'. Controlled Substance Manufacturer - Non-Prescription and $155.00 Veterina Non-Prescription Manufacturer - Medical Gases $130.00 Manufacturer - When licensed as a MN $105.00 Pharmac Medical Gas Distributors $50.00 Controlled Substance Researchers $25.00 Interns $20.00 Technicians $20.00

ID. LICENSING AND REGISTRATION A. Licensees as of June 30, 2002 TYPE NUMBER Pharmacists - Active 5670 Pharmacists - Inactive 73 Pharmacists - Emeritus 110 Technicians 5354 Pharmacies 1409 Wholesalers 773 Manufacturers 239 Medical Gas Distributors 35 Controlled Substance Researchers 193 Interns 605 Preceptors 913 B. New Licensees issued during biennium FY BY EXAM BY RECIPROCITY 2001 147 110 2002 212 75

" IV. COMPLAlNTS A. Complaints Received ITEM FY2001 FY 2002 1. Complaints Received 100 108 2. Complaints Per 1,000 Regulated Persons 8 8 3. Complaints by Type ofcomplaint A. Short counts 5 4 B. Dispensing error 51 53 C. Overcharging 0 1 D. Failed to counsel 2 1 E. Returned medications issue 0 2 F. No pharmacist on duty 1 0 G. Poor service to nursing home 2 0 H. Labeling error 4 2. 1. Prescribing without authority 1 0 J. Pharmacist is acting inappropriately 1 0 K. Billing problem 2 6 L. Insurance coverage/delay in getting prescription 2 1 M. Nursing home kickback - attempt 1 2 N. Violation ofprivacy 3 4 O. Dispensing without a prescription 3 7 P. No counseling - also labeling error 1 0 Q. Drug contamination 1 0 R. Refusal to fill prescription 1 1 S. Refusal to give copy 1 3 T. Numerous problems 1 5 U. Faxing prescriptions 1 0. V. Failure to detect allergy 0 2 W. Technician filled prescnptlon without 0 1 pharmacist checking it - dispensing error X. Unprofessional Conduct 8 4 Y. Discrimination 0 1 Z. Confrontation with pharmacist 0 4 AA. Generics 2 2 BB. Controlled substance record keeping 0 2 CC. Class II record keeping 0 1 DD. Breaking tablets 1 0 BE. Drug diversion 2 0 FF. Licensure issue 1 1 00. Drug frozen 1 0

"- ~- ~ B. Open Complaints on June 30 FY2001 FY 2002 23 21 3 Months 5 9 ths 10 8 onths 8 4 1 Year (Explain) 0 0 c. Closed Complaints on June 30 - We have not kept trackofthis information. ITEM FY 2001 FY2002 1. Number Closed 82 87 2. Dis osition by T ype A. Revocation B. Voluntary Surrender C. Sus ension 4 3 D. Restricted, Limited, or Conditional License 6 9 E. Civil Penalties F. Re rimand G. Agreement for Corrective Action H. Referral to HPSP 6 4 I. Dismissal or c10sure 66 71 3. Cases Closed That Were Open For More Than 0 0 One Year (Ex lain, IJ

v. TREND DATA AS OF JUNE 30 YEAR PERSONS COMPLAINTS COMPLAINTS OPEN LICENSED PER 1,000 CASES LICENSEES 2002 11024 108 10 21 2001 10169 100 10 23 2000 9495 75 8 13 1999 7863 60 8 7 1998 5388 67 12? 1997 5216 71 14? 1996 5185 90 17? 1995 5078 79 16? 1994 4832 66 14? 1993 4762 74 16.? 1992 4750 61 13? 1991 4690 41 9?